HCPCS Level II
J9301
Injection, obinutuzumab, 10 mg
Codes near J9301
These sit next to J9301 in the CMS Level II file. All J codes
- J9296Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
- J9297Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
- J9298Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
- J9299Injection, nivolumab, 1 mg
- J9300Injection, gemtuzumab ozogamicin, 5 mg
- J9302Injection, ofatumumab, 10 mg
- J9303Injection, panitumumab, 10 mg
- J9304Injection, pemetrexed (pemfexy), 10 mg
- J9305Injection, pemetrexed, not otherwise specified, 10 mg
- J9306Injection, pertuzumab, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 50242-0070-01 | Gazyva | Genentech, Inc. | 100 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.